ArticleJournal of pancreatic cancer2021

A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.

Peter Muscarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.